United Therapeutics (UTHR) Misses Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $494.63 -0.53%
Revenue Growth %: -1.2%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -1.2%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $4.36, $0.08 worse than the analyst estimate of $4.44. Revenue for the quarter came in at $614.7 million versus the consensus estimate of $575.1 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
